Recombinant Human Acid Ceramidase (Plexcera)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Acid Ceramidase (Plexcera)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAcid ceramidase stimulants
TargetsAcid ceramidase
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlexcera Therapeutics LLCMount Sinai Innovation Partners (MSIP)Icahn School Of Medicine At Mount Sinai
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A